0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Journal Articles

in Cancer Biomarkers

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Viewpoint  | 
How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy
Michael D. Farwell, MD; Amy S. Clark, MD, MSCE; David A. Mankoff, MD, PhD
JAMA Oncology
Original Investigation  | 
Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma
Nancy E. Thomas, MD, PhD; Sharon N. Edmiston, BS; Audrey Alexander, BS; et al.
JAMA Oncology
Invited Commentary  | 
Urinary Biomarkers for the Detection and Management of Localized Renal Cell Carcinoma
Brian I. Rini, MD; Steven C. Campbell, MD, PhD
JAMA Oncology
Original Investigation  | 
Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma:  A Prospective Cohort Study
Jeremiah J. Morrissey, PhD; Vincent M. Mellnick, MD; Jingqin Luo, PhD; et al.